|
⚲
|
| Keyboard |
| Fhm VII LP | |
|---|---|
| Firm | Frazier Management LLC |
| Address | 601 Union Street Suite 3200 Seattle, WA 98101 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Frazier Management LLC | |||||
| Frazier Healthcare VII-A LP | 021-196141 | Executive Officer | 82.5 M of 82.5 M |
23.6 M | |
| Frazier Healthcare VII LP | 021-180706 | Executive Officer | 293.9 M of 400.0 M |
74.7 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Imago BioSciences Inc IMGO
Common Stock
|
2021-07-20 | Conversion | 341,932 | ||
|
Imago BioSciences Inc IMGO
Series C Preferred Stock · derivative
|
2021-07-20 | Conversion | 64,360 | $0.00 | |
|
Imago BioSciences Inc IMGO
Series C Preferred Stock · derivative
|
2021-07-20 | Conversion | 225,850 | $0.00 | |
|
Imago BioSciences Inc IMGO
Series B Preferred Stock · derivative
|
2021-07-20 | Conversion | 740,673 | $0.00 | |
|
Imago BioSciences Inc IMGO
Series A Preferred Stock · derivative
|
2021-07-20 | Conversion | 1,199,890 | $0.00 | |
|
Imago BioSciences Inc IMGO
Series B Preferred Stock · derivative
|
2021-07-20 | Conversion | 211,069 | $0.00 | |
|
Imago BioSciences Inc IMGO
Series A Preferred Stock · derivative
|
2021-07-20 | Conversion | 341,932 | $0.00 | |
|
Imago BioSciences Inc IMGO
Common Stock
|
2021-07-20 | Buy | 145,918 | $16.00 | 2,334,688 |
|
Imago BioSciences Inc IMGO
Common Stock
|
2021-07-20 | Buy | 41,582 | $16.00 | 665,312 |
|
Imago BioSciences Inc IMGO
Common Stock
|
2021-07-20 | Conversion | 64,360 | ||
|
Imago BioSciences Inc IMGO
Common Stock
|
2021-07-20 | Conversion | 211,069 | ||
|
Imago BioSciences Inc IMGO
Common Stock
|
2021-07-20 | Conversion | 225,850 | ||
|
Imago BioSciences Inc IMGO
Common Stock
|
2021-07-20 | Conversion | 740,673 | ||
|
Imago BioSciences Inc IMGO
Common Stock
|
2021-07-20 | Conversion | 1,199,890 | ||
|
Iterum Therapeutics Ltd ITRM
6.500% Exchangeable Senior Subordinated Note due 2025 · derivative
|
2020-01-21 | Grant | 333,000 | $333,000.00 | 110,889,000,000 |
|
Iterum Therapeutics Ltd ITRM
6.500% Exchangeable Senior Subordinated Note due 2025 · derivative
|
2020-01-21 | Grant | 1,167,000 | $1,167,000.00 | 1,361,889,000,000 |
|
Iterum Therapeutics Ltd ITRM
Series B-1 Preferred Shares · derivative
|
2018-05-30 | Conversion | 53,899 | $0.00 | |
|
Iterum Therapeutics Ltd ITRM
Ordinary Shares
|
2018-05-30 | Buy | 354,949 | $13.00 | 4,614,337 |
|
Iterum Therapeutics Ltd ITRM
Ordinary Shares
|
2018-05-30 | Buy | 101,150 | $13.00 | 1,314,950 |
|
Iterum Therapeutics Ltd ITRM
Ordinary Shares
|
2018-05-30 | Conversion | 44,940 | ||
| showing 20 of 45 most recent transactions | |||||